BACKGROUND Hepatobiliary stone disease involves an intrahepatic bile duct stone that occurs above the confluence of the right and left hepatic ducts.One-step percutaneous transhepatic cholangioscopic lithotripsy(PTCSL...
Supported by Scientific Research project of Hunan Provincial Health Commission,No.B202303077689;Hunan Natural Science Foundation Project,No.2023JJ40397.
BACKGROUND Transhepatic arterial chemoembolization(TACE),as a local treatment,has been widely used in the treatment of unresectable liver cancer.The introduction of drug carrier microspheres has brought new hope for t...
BACKGROUND Transcatheter arterial chemoembolization(TACE)is the main treatment for patients with primary hepatocellular carcinoma(PHC)who miss the opportunity to undergo surgery.Conventional TACE(c-TACE)uses iodized o...
Biliary cancer is a highly aggressive disease that is typically diagnosed at advanced stages when surgical removal is no longer an option.In these cases,palliative care and mechanical widening of the blocked biliary s...
Supported by The Key Medical Specialty Nurturing Program of Foshan During The 14th Five-Year Plan Period,No.FSPY145205;The Medical Research Project of Foshan Health Bureau,No.20230814A010024;The Guangzhou Science and Technology Plan Project,No.202102010251;the Guangdong Science and Technology Program,No.2017ZC0222.
BACKGROUND Biliary stone disease is a highly prevalent condition and a leading cause of hospitalization worldwide.Hepatolithiasis with associated strictures has high residual and recurrence rates after traditional mul...
BACKGROUND Percutaneous transhepatic cholangiodrainage(PTCD)and endoscopic retrograde cholangiopancreatography/endoscopic nasobiliary drainage are the most common clinical procedures for jaundice control in patients w...
BACKGROUND Malignant obstructive jaundice(MOJ)is a condition characterized by varying degrees of bile duct stenosis and obstruction,accompanied by the progressive development of malignant tumors,leading to high morbid...
Supported by the National Natural Science Foundation of China,No.82173074;the Beijing Natural Science Foundation,No.7232127;the National High Level Hospital Clinical Research Funding,No.2022-PUMCH-D-001 and No.2022-PUMCH-B-004;the CAMS Innovation Fund for Medical Sciences,No.2021-I2M-1-002;the Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences,No.2018PT32014;Fundamental Research Funds for the Central Universities,No.3332019025.
BACKGROUND Percutaneous transhepatic stent placement has become a common strategy for the postoperative treatment of portal vein(PV)/superior mesenteric veins(SMV)stenosis/occlusion.It has been widely used after liver...
Hebei Provincial Department of Science and Technology[22377734D].
Background:Endoscopic ultrasound(EUS)-guided transhepatic antegrade stone removal(TASR)has been reserved for choledocholi-thiasis after failed endoscopic retrograde cholangiopancreatography(ERCP)in recent years.The ai...
BACKGROUND Primary hepatocellular carcinoma(HCC)is a common malignant tumour,and its early symptoms are often not obvious,resulting in many patients experiencing middle-to late-stage disease at the time of diagnosis.T...